75 related articles for article (PubMed ID: 2636208)
21. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
22. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
Qin YZ; Li JL; Zhu HH; Ruan GR; Li LD; Zhang Y; Xu LP; Liu DH; Liu YR; Huang XJ; Chen SS; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
[TBL] [Abstract][Full Text] [Related]
23. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Tricot G; Weber G
Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
[TBL] [Abstract][Full Text] [Related]
24. Tumor M2-PK levels in haematological malignancies.
Oremek GM; Rox S; Mitrou P; Sapoutzis N; Sauer-Eppel H
Anticancer Res; 2003; 23(2A):1135-8. PubMed ID: 12820361
[TBL] [Abstract][Full Text] [Related]
25. [Examination of interleukin levels and growth factor from blood platelets in leukemia].
Kiersnowska-Rogowska B; Rogowski F; Petelski T; Citko A; Jaroszewicz E; Bielawiec M
Pol Tyg Lek; 1996 May; 51(19-22):281-2, 288. PubMed ID: 9289710
[TBL] [Abstract][Full Text] [Related]
26. Increased levels of syndecan-1 in serum during acute graft-versus-host disease.
Seidel C; Ringdén O; Remberger M
Transplantation; 2003 Jul; 76(2):423-6. PubMed ID: 12883204
[TBL] [Abstract][Full Text] [Related]
27. Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML.
Lazarevic V; Golovleva I; Nygren I; Wahlin A
Am J Hematol; 2006 Jun; 81(6):470-1. PubMed ID: 16680752
[No Abstract] [Full Text] [Related]
28. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
[TBL] [Abstract][Full Text] [Related]
29. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis.
Soupir CP; Vergilio JA; Dal Cin P; Muzikansky A; Kantarjian H; Jones D; Hasserjian RP
Am J Clin Pathol; 2007 Apr; 127(4):642-50. PubMed ID: 17369142
[TBL] [Abstract][Full Text] [Related]
30. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
31. [Thyroid function in severe non-thyroidal diseases].
Földes J; Váradi G; Lakatos P; Bános C; Tarján G
Orv Hetil; 1989 Nov; 130(45):2415-8. PubMed ID: 2694058
[TBL] [Abstract][Full Text] [Related]
32. Molecular and phenotypic analysis of Philadelphia chromosome-positive bilineage leukemia: possibility of a lineage switch from T-lymphoid leukemic progenitor to myeloid cells.
Monma F; Nishii K; Ezuki S; Miyazaki T; Yamamori S; Usui E; Sugimoto Y; Lorenzo V F; Katayama N; Shiku H
Cancer Genet Cytogenet; 2006 Jan; 164(2):118-21. PubMed ID: 16434313
[TBL] [Abstract][Full Text] [Related]
33. [Neutrophil function in hematologic disorders].
Matzner Y
Harefuah; 1991 Dec; 121(11):449-52. PubMed ID: 1786895
[No Abstract] [Full Text] [Related]
34. Effect of nomifensine on cortisol, prolactin and biogenic amines in neurotic depressed patients.
Rettori V; Rubio M; Seilicovich A; Malik A; de los Santos A
Neuropsychobiology; 1983; 10(4):209-12. PubMed ID: 6676675
[TBL] [Abstract][Full Text] [Related]
35. [Spurious hypoglycemia and chronic myeloid leukemia].
de Sas M; Fernández G; Novoa F
Med Clin (Barc); 1991 Mar; 96(9):356. PubMed ID: 2046447
[No Abstract] [Full Text] [Related]
36. [Evaluating the success of blood transfusion with erythrocytes preserved in different ways].
Zschoch S; Matthes G; Ihle R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):629-40. PubMed ID: 2465243
[TBL] [Abstract][Full Text] [Related]
37. A case-control study of the effects of hydroxyurea on circulating cortisol levels in patients with acute myelogenous leukemia and chronic myeloproliferative disorders.
Navarra P; Aloe-Spiriti MA; Boccarini F; Montefusco E; Latagliata R; Preziosi P; Petti MC
Pharmacol Res; 2000 Oct; 42(4):389-92. PubMed ID: 10988000
[TBL] [Abstract][Full Text] [Related]
38. Immunoreactive calcitonin: a tumor marker for myelogenous leukemias.
Foa P; Ortolani S; Pogliani EM; Iurlo A; Gualdoni A; Maiolo AT; Polli EE
Int J Biol Markers; 1990; 5(1):27-30. PubMed ID: 2230349
[TBL] [Abstract][Full Text] [Related]
39. Purine nucleotide content of polymorphonuclear leukocytes from acute and chronic myeloid leukemia patients.
Pagani R; Tabucchi A; Consolmagno E; Carlucci F; Pizzichini M; Marinello E; Leoncini R
Biochem Soc Trans; 1994 May; 22(2):243S. PubMed ID: 7958303
[No Abstract] [Full Text] [Related]
40. [Observation of cardiac function, hemorheology and lingual microcirculation of leukemic patients].
Chen SY; Lin YC; Cui ZY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Mar; 15(3):156-8. PubMed ID: 7647531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
